Charles River hints at accelerating pace of M&A activity 27-Nov-2019 By Nick Taylor Charles River Laboratories points to potential to accelerate rate of mergers and acquisitions to hit goal of doubling revenues every five years.
Charles River to acquire Citoxlab, M&A ‘a top priority’ 14-Feb-2019 By Melissa Fassbender Charles River is set to acquire Citoxlab for €448m ($510m) in cash, a deal which would bolster the CRO’s safety assessment portfolio to support its long-term organic growth aspirations, says CEO.